MGB Berhad (KLSE:MGB) Is Experiencing Growth In Returns On Capital
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on MGB Berhad is:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.12 = RM80m ÷ (RM1.1b - RM449m) (Based on the trailing twelve months to December 2024).
So, MGB Berhad has an ROCE of 12%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Construction industry average of 10.0%.
Check out our latest analysis for MGB Berhad
Above you can see how the current ROCE for MGB Berhad compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering MGB Berhad for free.
The trends we've noticed at MGB Berhad are quite reassuring. Over the last five years, returns on capital employed have risen substantially to 12%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 30%. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.
All in all, it's terrific to see that MGB Berhad is reaping the rewards from prior investments and is growing its capital base. Considering the stock has delivered 16% to its stockholders over the last five years, it may be fair to think that investors aren't fully aware of the promising trends yet. So exploring more about this stock could uncover a good opportunity, if the valuation and other metrics stack up.
MGB Berhad does have some risks though, and we've spotted 2 warning signs for MGB Berhad that you might be interested in.
For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
TELUS (TSX:T) Increases Dividend 7% Amid CAD 285M Goodwill Impairment
TELUS recently announced a 7% increase in its quarterly dividend and disclosed a significant impairment of CAD 285 million, which coincided with the release of its second-quarter earnings showing a decline in net income to CAD 7 million from the previous year. These developments may have added weight to TELUS's 7.72% price move in the last quarter. Despite positive revenue growth, the broader market witnessed fluctuations, including sharp declines influenced by international tariffs and a weaker-than-expected U.S. jobs report. This complexity in market dynamics highlights how mixed company news can interact with external market pressures. TELUS has 2 weaknesses we think you should know about. Uncover the next big thing with financially sound penny stocks that balance risk and reward. TELUS's recent dividend increase and impairment announcement have potential implications for its revenue and earnings outlook. While the dividend uptick signals confidence in future cash flows, the CAD 285 million impairment might constrain short-term profitability. The share price's 7.72% quarterly movement reflects reactions to these mixed signals, amidst broader market volatility. Over the past five years, TELUS achieved a total return of 22.52%, providing a broader context for its somewhat stable growth trajectory. Recent news impacts TELUS's revenue and earnings forecasts, as analysts anticipate gradual revenue growth and margin improvements. While the company faces competitive pressures, its diversification into health and agriculture might sustain revenue streams. However, with the current share price at CA$22.32 and the analyst price target at CA$23.34, the price difference suggests a limited upside potential in the near term, indicating that the stock is approaching its estimated fair value, according to consensus estimates. In the last year, TELUS surpassed the Canadian Telecom industry's return of 13.9%, though it underperformed against the broader Canadian market's 17.0% return. This comparative performance underscores TELUS's resilience in a challenging market landscape, supported by its diversified business model and strategic investments aimed at long-term growth. Understand TELUS' earnings outlook by examining our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:T. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
7 hours ago
- Yahoo
Service Corporation International Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line
Service Corporation International (NYSE:SCI) Second Quarter 2025 Results Key Financial Results Revenue: US$1.07b (up 3.0% from 2Q 2024). Net income: US$122.9m (up 4.0% from 2Q 2024). Profit margin: 12% (in line with 2Q 2024). EPS: US$0.87 (up from US$0.81 in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Service Corporation International Revenues Beat Expectations Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) was mostly in line with analyst estimates. Looking ahead, revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 9.6% growth forecast for the Consumer Services industry in the US. Performance of the American Consumer Services industry. The company's share price is broadly unchanged from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 2 warning signs for Service Corporation International you should be aware of, and 1 of them doesn't sit too well with us. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
Anika Therapeutics Second Quarter 2025 Earnings: Beats Expectations
Anika Therapeutics (NASDAQ:ANIK) Second Quarter 2025 Results Key Financial Results Revenue: US$28.2m (down 33% from 2Q 2024). Net loss: US$4.65m (loss widened by US$4.56m from 2Q 2024). US$0.32 loss per share (further deteriorated from US$0.006 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Anika Therapeutics Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Looking ahead, revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 27% from a week ago. Risk Analysis It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Anika Therapeutics, and understanding this should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data